Marvel’s OTCQB Symbol Changes to MARVF
VANCOUVER, BC / ACCESSWIRE / June 24, 2021 / Marvel Discovery Corp. (TSX-V:MARV), (Frankfurt:O4T1), (MARVF:OTCQB);…
VANCOUVER, BC / ACCESSWIRE / June 24, 2021 / Marvel Discovery Corp. (TSX-V:MARV), (Frankfurt:O4T1), (MARVF:OTCQB);…
Release Highlights: Term Sheet signed with Mission World Group for delivery of power for 3000…
Report highlights record-setting zero day malware volumes, rising network attack rates and the quarter’s top…
Paris – June 24, 2021 Capital Banking Solutions, the global provider of integrated banking software…
Fully operational unit on display at the company’s HQ in Cambridge, UK DataQube Global Ltd,…
ZURICH, SWITZERLAND, 24.06.2021 – SANDSIV, EMEA’s leading customer experience management solution provider, has won the…
Integrated Service Assurance solution empowers proactive network management Fairfax, VA, USA, 24 June 2021 –…
OSLO, Norway, June 24, 2021 /PRNewswire/ — The way people use the web is changing and…
The Company has finalized a ten-year $12 million licensing agreement with a Dubai Company LOS…
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN…
NovoBiome and INRAE, a new Associated Partner Laboratory on human gut microbiota New partnership to…
If approved, PDS would be the first and only eye implant with continuous drug delivery…
Pratteln, Switzerland, and Rockville, MD, USA, June 24, 2021 – Santhera Pharmaceuticals (SIX: SANN) and ReveraGen…
Acquires all royalty rights to Maxigesic® IV Assumes sole responsibility for HY-075 and HY-038 –…
– Data from Phase 3 study of Yselty® (linzagolix) for the treatment of uterine…
MONTEGO BAY, Jamaica, June 24, 2021 (GLOBE NEWSWIRE) — Silo Wellness Inc. (“Silo Wellness” or…
BOSTON, June 23, 2021 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE), a biotechnology…
The PMDA enters 8th consecutive year of using Certara’s biosimulation software PRINCETON, N.J., June 23,…
MALVERN, Pa., June 23, 2021 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical…
Study highlights the clinical performance of NIS4® technology in diagnosing at-risk NASH in patients with…